19:42 , Oct 3, 2017 |  BC Innovations  |  Distillery Therapeutics

Musculoskeletal

INDICATION: Musculoskeletal Mouse studies suggest activating ADAMTS1 could help treat muscle injury. In a mouse model of muscle injury, levels of ADAMTS1 were higher in the injured muscle than in the contralateral uninjured muscle. Also...
07:00 , Jul 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer; metastases Matrix metalloproteinase 1 (MMP1); ADAM metallopeptidase with thrombospondin type 1 motif 1 (ADAMTS1); epidermal growth factor receptor (EGFR) Studies in mice and...
07:00 , Jul 23, 2009 |  BC Innovations  |  Targets & Mechanisms

Short-circuiting metastases

A U.S.-Dutch research team has shown that Src inhibitors in development to treat primary cancers could also prevent metastatic bone tumors after surgical removal of a breast tumor. 1 The question is whether Src inhibitors...